1,755 filings
Page 32 of 88
6-K
wbhbeqbhr w39ip
31 Jul 14
Teva Reports Second Quarter 2014 Results
12:00am
6-K
5rib bawe
30 Jul 14
All Proposals Approved At Teva’s Annual Meeting of Shareholders
12:00am
6-K
dcg4eoydiv
21 Jul 14
Live Filing
12:00am
6-K
kte0b4d4w9w1n
18 Jul 14
Live Filing
12:00am
6-K
ew6u76vq9ipn 9227a
16 Jul 14
Leading U.S. Proxy Advisory Firm Supports Teva Nominees and Other Shareholders’ Meeting Proposals
12:00am
6-K
c0h2pjcjn29
14 Jul 14
First Breath-Actuated Dry-Powder SABA Inhaler to be Accepted by FDA for Review
12:00am
UPLOAD
z0az8
7 Jul 14
Letter from SEC
12:00am
6-K
avqzjxsydmmgr5
3 Jul 14
Current report (foreign)
12:00am
6-K
42b wddz2q8us7re8cn
3 Jul 14
Current report (foreign)
12:00am
6-K
jja62xhjae zy2hoqdu
20 Jun 14
Teva Reaches Settlement In Proair®hfa Patent Case
12:00am
CORRESP
2s4un
18 Jun 14
Correspondence with SEC
12:00am
6-K
omon2nflkw7r uas04w
18 Jun 14
Current report (foreign)
12:00am
6-K
xac11mg ztlrl
18 Jun 14
Chairman of the Board
12:00am
CORRESP
o2s pb10me5vgv4v5
18 Jun 14
Correspondence with SEC
12:00am
6-K
xhk1pt
17 Jun 14
Teva Reaches Settlements In Nuvigil® Patent Case
12:00am
6-K
qsc7f7qtu1kle
12 Jun 14
Teva Announces U.s. Court of Appeals Upholds Ruling Confirming Invalidity of Baraclude® Patent
12:00am
UPLOAD
y2wiy
10 Jun 14
Letter from SEC
12:00am
6-K
9xex0g1
9 Jun 14
FDA Approves Expanded Label for AZILECT® for Treatment Across All Stages of Parkinson’s Disease
12:00am
6-K
zab5dg
5 Jun 14
Teva to Present at the Goldman Sachs 35th Annual Global Healthcare Conference
12:00am
6-K
bn7vc1b73gq
3 Jun 14
Live Filing
12:00am